Rīgas 1. slimnīca ir Latvijas ārstniecības iestāde, kas atrodas Rīgas Centra rajonā. Kopš 2009. gada slimnīca piedāvā ambulatoru, dienas stacionāra palīdzību un diagnostiku.

During the past decade, RiGa 1st Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "RiGa 1st Hospital" #1 sponsor was "Boehringer Ingelheim" with 1 trials, followed by "Janssen Research & Development, LLC" with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "PregLem SA" with 1 trials sponsored and "Zuzana Zbožínková, M.Sc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "RiGa 1st Hospital" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "RiGa 1st Hospital" are "Arthritis, Psoriatic" (1 trials), "Bronchiectasis" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Psoriasis" (1 trials) and "Uterine Fibroids" (1 trials). Many other conditions were trialed in "RiGa 1st Hospital" in a lesser frequency.

Most popular intervention types in "RiGa 1st Hospital" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BI 1291583" (1 trials), "Guselkumab" (1 trials), "PF-06700841" (1 trials) and "Vehicle (Placebo)" (1 trials). Other intervention names were less common.

The vast majority of trials in "RiGa 1st Hospital" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "RiGa 1st Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in RiGa 1st Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in RiGa 1st Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".